AstraZeneca reports coronavirus vaccine up to 90% effective in late-stage trials

The vaccine is reportedly less expensive and easier to distribute than some of those from competitors.

Published: November 23, 2020 7:20am

Updated: November 23, 2020 4:33pm

AstraZeneca said Monday its coronavirus vaccine has been up to 90% effective in late-stage trials, becoming the third pharmaceutical company in recent weeks to announce promising results that could soon lead to worldwide vaccinations.

The vaccine is less expensive and easier to distribute than some of those from competitors, according to the Associated Press.

The results are based on trials in the U.K. and Brazil from a vaccine developed by Oxford University and manufactured by AstraZeneca, the wire service also reports.

The two other pharmaceutical companies to recently announce clinical trial results with effectiveness of at least 90% are Pfizer and Moderna. 

Unlock unlimited access

  • No Ads Within Stories
  • No Autoplay Videos
  • VIP access to exclusive Just the News newsmaker events hosted by John Solomon and his team.
  • Support the investigative reporting and honest news presentation you've come to enjoy from Just the News.
  • Just the News Spotlight

    Support Just the News